Peter C. Goodhand

Investor

President (Interim) FACIT Inc at FACIT (Fight Against Cancer Innovation Trust)

Find your path to Peter

15 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.

Michael JenkinsunlockedPeter: together at FACIT (Fight Against Cancer Innovation Trust)

×11Peter: together at FACIT (Fight Against Cancer Innovation Trust)

About

Experienced health innovation and commercialization executive who is past President of OICR and former President and CEO of the Canadian Cancer Society. He is currently CEO of the Global Alliance for Genomics and Health (GA4GH).

Colleagues at FACIT (Fight Against Cancer Innovation Trust)

Connie Chen

Senior Director, Strategy and Corporate Development at FACIT (Fight Against Cancer Innovation Trust)

David Koehler

Director, Fund Operations at FACIT (Fight Against Cancer Innovation Trust)

David O'Neill

President at FACIT (Fight Against Cancer Innovation Trust)

Elizabeth Douville

Investment Committee Chair at FACIT (Fight Against Cancer Innovation Trust)

Enrico D'Angelo

CFO at Parkwalk Advisors

Francesca Chappell

Chief Finance Officer at BP Marsh & Partners PLC

Kelly Holman

Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)

Ken Newport

Board Director at FACIT (Fight Against Cancer Innovation Trust)

Frequently asked questions

Who is Peter C. Goodhand?: Experienced health innovation and commercialization executive who is past President of OICR and former President and CEO of the Canadian Cancer Society. He is currently CEO of the Global Alliance for Genomics and Health (GA4GH).
Where does Peter C. Goodhand work?: Peter C. Goodhand is President (Interim) FACIT Inc at FACIT (Fight Against Cancer Innovation Trust).